Volitionrx Ltd (VNRX)

$0.68 +0.01 (2.07%)
Market Cap 71.01M
Revenue (ttm) 1.23M
Net Income (ttm) -26.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,192.68%
Debt to Equity Ratio -0.21
Volume 135,089
Avg Vol 207,524
Day's Range N/A - N/A
Shares Out 107.60M
Stochastic %K 34%
Beta 1.26
Analysts Strong Sell
Price Target $3.10

Company Profile

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progre...

Industry: Medical Devices
Sector: Healthcare
Phone: 646 650 1351
Address:
1489 West Warm Springs Road, Suite 110, Henderson, United States
ZacksSCR
ZacksSCR Aug. 25 at 1:56 PM
$VNRX: Management seeks to secure multiple licensing agreements in the human diagnostic space with the first one expected in 3Q 2025. Key financial goal for 2025 is to be cash neutral on a full year basis. https://buff.ly/Quu9UDr
0 · Reply
2021er
2021er Aug. 19 at 8:37 AM
$VNRX https://fintel.io/so/us/vnrx/citadel-advisors-llc
0 · Reply
Amcollins711
Amcollins711 Aug. 17 at 3:30 PM
$VNRX https://www.marketbeat.com/instant-alerts/d-boral-capital-reiterates-buy-rating-for-volitionrx-nysevnrx-2025-08-15/ Give this pretty penny some love, I think she'll give it right back!
0 · Reply
StockScanners
StockScanners Aug. 16 at 3:25 AM
$VNRX keep watch if this holds above .57
0 · Reply
Amcollins711
Amcollins711 Aug. 15 at 5:21 PM
$VNRX Armistice twisted my "arm" on this one... recent insider buys swindled me too. New love child @sirspanky ??? Needs volume, I know I know...
0 · Reply
MurraytheMoose
MurraytheMoose Aug. 15 at 5:08 PM
$VNRX Give us the money! Be aggressive. Negotiate. Fire Cam. Something!!!
0 · Reply
2021er
2021er Aug. 15 at 4:18 PM
$VNRX
0 · Reply
Stronghand21
Stronghand21 Aug. 15 at 4:00 PM
$VNRX Nice!
0 · Reply
DARKP00L
DARKP00L Aug. 15 at 3:38 PM
$VNRX this stock is seeing a surge in interest. Market volatility might ensue!
0 · Reply
DARKP00L
DARKP00L Aug. 15 at 3:13 PM
$VNRX this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
Latest News on VNRX
VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript

Aug 15, 2025, 2:24 PM EDT - 13 days ago

VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update

Aug 14, 2025, 4:10 PM EDT - 13 days ago

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update

VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update

Aug 8, 2025, 8:30 AM EDT - 20 days ago

VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

Aug 4, 2025, 4:01 PM EDT - 23 days ago

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation

Jul 16, 2025, 8:00 AM EDT - 6 weeks ago

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

Jul 8, 2025, 8:00 AM EDT - 7 weeks ago

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

Jun 12, 2025, 8:30 AM EDT - 2 months ago

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

Jun 4, 2025, 9:00 PM EDT - 3 months ago

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats

May 19, 2025, 8:30 AM EDT - 3 months ago

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats

VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript

May 16, 2025, 7:19 PM EDT - 3 months ago

VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript

VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update

May 15, 2025, 5:37 PM EDT - 3 months ago

VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

May 12, 2025, 8:30 AM EDT - 3 months ago

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption

May 7, 2025, 8:30 AM EDT - 4 months ago

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets

Apr 29, 2025, 8:30 AM EDT - 4 months ago

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets

VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 12:31 AM EDT - 5 months ago

VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

Mar 31, 2025, 4:05 PM EDT - 5 months ago

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025

Mar 28, 2025, 8:00 AM EDT - 5 months ago

Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025

Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025

Mar 27, 2025, 8:30 AM EDT - 5 months ago

Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering

Mar 26, 2025, 8:00 AM EDT - 5 months ago

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Mar 25, 2025, 9:30 AM EDT - 5 months ago

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry

Mar 21, 2025, 8:30 AM EDT - 5 months ago

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer

Mar 20, 2025, 8:30 AM EDT - 5 months ago

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer

Volition Proudly Sponsors the 44th ISICEM Congress

Mar 17, 2025, 8:30 AM EDT - 5 months ago

Volition Proudly Sponsors the 44th ISICEM Congress

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Mar 13, 2025, 8:30 AM EDT - 6 months ago

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Mar 11, 2025, 8:30 AM EDT - 6 months ago

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Mar 4, 2025, 8:30 AM EST - 6 months ago

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Feb 28, 2025, 8:30 AM EST - 6 months ago

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

Feb 6, 2025, 8:30 AM EST - 7 months ago

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025

Feb 5, 2025, 9:15 AM EST - 7 months ago

Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025

Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis

Jan 30, 2025, 8:30 AM EST - 7 months ago

Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis

Volition Issues Business Review 2024

Jan 8, 2025, 8:30 AM EST - 8 months ago

Volition Issues Business Review 2024

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Dec 12, 2024, 8:00 AM EST - 9 months ago

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening

Dec 10, 2024, 8:00 AM EST - 9 months ago

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

Dec 6, 2024, 9:00 AM EST - 9 months ago

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 11:47 AM EST - 10 months ago

VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript

VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update

Nov 14, 2024, 4:10 PM EST - 10 months ago

VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update

VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update

Nov 8, 2024, 8:00 AM EST - 10 months ago

VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update

Volition Appoints Timothy I. Still as Chairman

Nov 6, 2024, 4:10 PM EST - 10 months ago

Volition Appoints Timothy I. Still as Chairman

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating

Oct 31, 2024, 8:00 AM EDT - 10 months ago

Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Oct 9, 2024, 8:00 AM EDT - 11 months ago

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

Oct 3, 2024, 8:00 AM EDT - 11 months ago

Volition hosts NETs in sepsis management symposium at ESICM Lives 2024

Volition Appoints Dr. Ethel Rubin as an Independent Director

Sep 30, 2024, 4:10 PM EDT - 11 months ago

Volition Appoints Dr. Ethel Rubin as an Independent Director

Volition Hosts KOL Roundtable on Sepsis

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Volition Hosts KOL Roundtable on Sepsis

VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 12:11 PM EDT - 1 year ago

VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript

VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update

Aug 14, 2024, 4:10 PM EDT - 1 year ago

VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update

VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering

Aug 9, 2024, 8:00 AM EDT - 1 year ago

VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering

VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update

Aug 6, 2024, 8:00 AM EDT - 1 year ago

VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update

Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting

Jun 27, 2024, 8:00 AM EDT - 1 year ago

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jun 14, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

ZacksSCR
ZacksSCR Aug. 25 at 1:56 PM
$VNRX: Management seeks to secure multiple licensing agreements in the human diagnostic space with the first one expected in 3Q 2025. Key financial goal for 2025 is to be cash neutral on a full year basis. https://buff.ly/Quu9UDr
0 · Reply
2021er
2021er Aug. 19 at 8:37 AM
$VNRX https://fintel.io/so/us/vnrx/citadel-advisors-llc
0 · Reply
Amcollins711
Amcollins711 Aug. 17 at 3:30 PM
$VNRX https://www.marketbeat.com/instant-alerts/d-boral-capital-reiterates-buy-rating-for-volitionrx-nysevnrx-2025-08-15/ Give this pretty penny some love, I think she'll give it right back!
0 · Reply
StockScanners
StockScanners Aug. 16 at 3:25 AM
$VNRX keep watch if this holds above .57
0 · Reply
Amcollins711
Amcollins711 Aug. 15 at 5:21 PM
$VNRX Armistice twisted my "arm" on this one... recent insider buys swindled me too. New love child @sirspanky ??? Needs volume, I know I know...
0 · Reply
MurraytheMoose
MurraytheMoose Aug. 15 at 5:08 PM
$VNRX Give us the money! Be aggressive. Negotiate. Fire Cam. Something!!!
0 · Reply
2021er
2021er Aug. 15 at 4:18 PM
$VNRX
0 · Reply
Stronghand21
Stronghand21 Aug. 15 at 4:00 PM
$VNRX Nice!
0 · Reply
DARKP00L
DARKP00L Aug. 15 at 3:38 PM
$VNRX this stock is seeing a surge in interest. Market volatility might ensue!
0 · Reply
DARKP00L
DARKP00L Aug. 15 at 3:13 PM
$VNRX this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
JarvisFlow
JarvisFlow Aug. 15 at 2:34 PM
D. Boral Capital has adjusted their stance on VolitionRX ( $VNRX ), setting the rating to Buy with a target price of 5.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Aug. 14 at 8:02 PM
$VNRX signal 54.5%
0 · Reply
Stronghand21
Stronghand21 Aug. 14 at 6:11 PM
$VNRX Took a nibble on those insider buys as well.
0 · Reply
cinmos44
cinmos44 Aug. 13 at 8:59 PM
$VNRX Stock will go up before earnings call 8/15 afterhours Great buy!
0 · Reply
ABM016
ABM016 Aug. 6 at 3:08 PM
$VNRX +insider trans
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 6 at 3:05 PM
$VNRX CEO purchased 78,125 shares at $0.64 for a total of $50,000. Reynolds Cameron John now owns 3,651,641 shares. https://ceo-buys.com
0 · Reply
MGeronimo
MGeronimo Aug. 6 at 2:23 PM
$VNRX SHOULD PUSH OVER A $1
0 · Reply
MGeronimo
MGeronimo Aug. 6 at 2:22 PM
$VNRX SDDING AT .66 heavy on insider buying
0 · Reply
BstnGeorge
BstnGeorge Aug. 6 at 1:17 PM
$VNRX VNRX's CEO purchased 78,125 shares at $0.64 for a total amount of $50,000 on Aug 05. The CEO now owns 3,651,641 shares.
0 · Reply
shapenkaas
shapenkaas Aug. 4 at 8:07 PM
$VNRX another shitty capital increase.
1 · Reply
MeetyaMaker
MeetyaMaker Aug. 2 at 12:26 AM
$VNRX how’s this company still in compliance on nasdaq?
4 · Reply
2021er
2021er Jul. 30 at 4:09 PM
$VNRX 🫠
1 · Reply